Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs



Summary



GBI Research, the leading business intelligence provider, has released its latest report, “Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs”, which provides key data, information and analysis of CRO industry. The report provides a comprehensive insight into the size of the CRO market, and includes forecasts, key reasons for outsourcing, technology developments affecting CRO’s, public private partnerships, profiles of top CROs, drivers and restraints and deals analysis.

This report is built using data and information sourced from proprietary databases, primary and secondary research and uses in-house analysis from GBI Research’s team of industry experts.

CRO industry market revenues were estimated to total $21.4 billion in 2010. In 2009 the revenues recorded were $19.1 billion. From 2009 to 2010 the industry grew at the rate of 12% which is considered to be very healthy in comparison to the other R&D industry growth. According to clinicaltrials.gov by November 2011, 43.9% of the clinical trials were carried out in the US. 22.9% of the trials were carried out in Europe. 11.6% of the trials were carried out in Asia and the rest of the clinical trials were carried out in Canada, Mexico, Australia, Middle East and Africa approximating 21.4% of the total clinical trials. GBI research estimates that the global R&D outsourcing market in 2010 was 25.3% of the total pharmaceutical R&D expenditure. The expenditure is estimated to increase at the rate of 5% annually and is expected to reach 37.1% of the total R&D expenditure by 2018. All the companies are looking to cut down the time for launch of drugs along with a reduction in the expenditure on R&D.



Scope


- Detailed overview of the CRO industry.
- Annualized market data and forecasts for the CRO market.
- Detailed overview of key reasons behind outsourcing, outsourcing service models and key drivers and restraints of the market.
- Analysis of the key technologies that affect CRO industry
- Analysis of public private partnerships with case studies.
- Company profiles of major CROs, key services offered, financial information and presence in APAC
- Analysis of partnership deals and M&A deals involving key companies.



Reasons to buy


- Develop market-entry and market expansion strategies by identifying areas for high growth and opportunities.
- Understand the factors shaping the CRO market.
- Identify the top players in the CRO market, financial revenues, geographical presence and key services offered.
- Analyze the key geographies that are lucrative markets for the outsourcing of clinical research.
- Analyze the trends in licensing and M&A deals and explore potential investment opportunities
- Understand upcoming trends that are poised to drive the future growth of the CRO industry.

Table Of Contents

Table of Contents
1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 9
1.2 List of Figures 10
2 Introduction 12
3 Contract Research Organization Market to 2018 - Overview 13
3.1 Global Contract Research Organizations 13
3.1.1 Clinical Research Process 13
3.1.2 Drug Discovery Phase 13
3.1.3 Pre-Clinical Phase 13
3.1.4 Phase I 13
3.1.5 Phase II 13
3.1.6 Phase III 13
3.1.7 Review and Approval from Regulatory Agencies 14
3.1.8 Post-marketing Studies 14
3.2 Key Reasons Outsourcing Clinical Trials and Research Processes 14
3.2.1 Different Strategies Adopted by the Pharmaceutical Companies to Increase the Efficiency 14
3.2.2 Increase in RandD Costs Compared to Revenue Growth 15
3.2.3 Increasing Drug Failure Rates a Concern for Pharmaceutical Companies 16
3.2.4 Less Time Required to Launch a Product in the Market 16
3.2.5 Outsourcing to Site Management Organizations 17
3.2.6 Minimization of Development Risks through Risk Sharing 18
3.2.7 Contract Research Organizations can Effectively Manage the Trends in Regulations Governing Clinical Trials 18
4 Contract Research Organization Market to 2018 - Important Trends in Regulatory Aspects of Contract Research Organizations 19
4.1 New Pharmacovigilance Legislation 19
4.1.1 Reasons for Passing the New Legislation 19
4.2 Important Regulations by Food and Drug Administration in Proposal 19
4.2.1 Exculpatory Language to be Used in Informed Consent Forms 19
4.2.2 Risk-based Approach to Monitoring Strategies 19
4.3 Food and Drug Administration Motivating Contract Research Organizations to Use Adaptive Design in Drug Development 19
5 Contract Research Organization Market to 2018 - Technology Developments to Benefit Contract Research Organizations 20
5.1 Analytics and Intelligence to Meet Contract Research Organizations’ High Expectations 20
5.2 Technological Developments in Clinical Research 20
5.2.1 Biomarkers 20
5.2.2 Nanotechnology 20
5.2.3 Genomics, Proteomics and Metabolomics 21
5.2.4 Toxicogenomics 21
5.2.5 Surgical Models 21
5.2.6 Transgenic Animal Models 21
5.2.7 Simulation Models 22
5.3 Information Technology in RandD 22
5.3.1 Data Management 22
5.3.2 Clinical Data Management System 22
5.3.3 Clinical Data Management Outsourcing 23
5.3.4 Deals in Clinical Trial Data Management Outsourcing 24
5.4 Technology Support Will Be Fundamental to Future of Personalized Medicine 25
5.5 eClinical Trial Solutions 26
5.5.1 Clinical Trial Management System 26
5.5.2 Electronic Data Capture 27
5.5.3 Using Virtual Technology to Reduce RandD Costs and Time 27
6 Contract Research Organization Market to 2018: Internal Reorganization 28
6.1 Restructuring RandD 28
6.1.1 GlaxoSmithKline - Realigning Focus to Vaccines, Consumer Healthcare and Emerging Markets 29
6.1.2 Pfizer - Redefining the Research Focus and Outsourcing the Rest 30
6.1.3 AstraZeneca - Consolidating RandD Facilities with Narrowed Therapeutic Focus 31
6.1.4 Sanofi - Combining Workforce Consolidation with Externalization to Safeguard Future Revenue 32
7 Contract Research Organization Market to 2018 - Public-Private Partnerships 33
7.1 Public-Private Partnerships 33
7.1.1 Public-Private Partnerships for RandD in the Pharmaceutical Industry 33
7.2 Private-Government Partnerships 34
7.2.1 Innovative Medicine Initiative in Europe 34
7.2.2 Cooperative Research and Development Agreements in the US 36
7.2.3 Cooperative Research and Development Agreement for Pharmaceutical RandD 36
7.2.4 Small Business Innovation Research Program 37
7.2.5 Public-Private Partnership in India 38
7.2.6 Blockbusters from the US Funding 38
7.2.7 Technology Transfer Issues 39
7.2.8 Laws Enabling Technology Transfer in the US 41
7.3 Open-source RandD 42
7.4 Crowdsourcing 42
7.4.1 Applicability of Crowdsourcing to the Pharmaceutical Industry 43
8 Contract Research Organization Market to 2018: Market Characterization 44
8.1 Global Clinical Trial Market 44
8.2 Global Pharmaceutical RandD Outsourcing Market 45
8.3 Global Contract Research Organization Market by Geography 46
8.4 Trend Analysis of Contract Research Organization Market by Geography 47
8.5 Global Contract Research Organization Market by Phase 48
8.6 Trend Analysis of Contract Research Organization Market by Phase 49
9 Contract Research Organization Market to 2018: Geographical Landscape 50
9.1 Emerging Regions in the Global Contract Research Organization Market: Argentina 50
9.2 Domestic Contract Research Organization Profiles 51
9.2.1 Abel Santos and Asociados 51
9.2.2 Activa CRO 52
9.2.3 Blanchard and Asociados 53
9.2.4 EGCP 54
9.2.5 Klixar 55
9.2.6 LatinClin 56
9.2.7 Mmatiss 57
9.2.8 Estudios Clínicos Latinoamerica 58
9.3 Emerging Regions in the Global Contract Research Organization Market: India 59
9.4 Domestic Contract Research Organization Profiles 60
9.4.1 Reliance Life Sciences 60
9.4.2 Asian Clinical Trials 61
9.4.3 DiagnoSearch Life Sciences 62
9.4.4 ClinInvent 63
9.4.5 Synchron Research Services Pvt Ltd 64
9.4.6 Lambda Therapeutic Research Ltd 65
9.4.7 GVK Biosciences Pvt Ltd 66
9.4.8 Veeda Clinical Research Ltd 67
9.4.9 Ecron Acunova 68
9.4.10 Siro Clinpharm Pvt Ltd 69
9.5 Emerging Regions in the Global Contract Research Organization Market: China 70
9.6 Domestic Contract Research Organizations 71
9.6.1 Boji Medicine Services Co. Ltd 71
9.6.2 Giant Med-Pharma Services Inc 72
9.6.3 InCrom 73
9.6.4 Pharmaron 74
9.6.5 Venturepharm Service Group 75
10 Contract Research Organization Market to 2018: Competitive Landscape 76
10.1 Overview 76
10.2 Market Share Analysis 76
10.3 Quintiles Transnational Corp 78
10.3.1 Business Description 78
10.3.2 Recent MandA Deals and Strategic Alliances 79
10.4 Covance Inc 81
10.4.1 Business Description 81
10.4.2 Recent MandA Deals and Alliances 82
10.5 ICON 83
10.5.1 Business Overview 83
10.5.2 Recent MandA Deals and Analysis 84
10.6 Pharmaceutical Product Development Inc 85
10.6.1 Business Description 85
10.6.2 Recent MandA Deals and Alliances 86
10.7 Charles River Laboratories International, Inc 88
10.7.1 Business Description 88
10.7.2 Recent MandA Deals and Alliances 89
10.8 Parexel International 90
10.8.1 Business Description 90
10.8.2 Recent MandA Deals and Alliances 91
11 Contract Research Organization Market to 2018 - Appendix 92
11.1 Market Definitions 92
11.2 Abbreviations 92
11.3 Sources 94
11.4 Note 94
11.5 Research Methodology 94
11.5.1 Coverage 95
11.5.2 Secondary Research 95
11.5.3 Primary Research 95
11.5.4 Expert Panel Validation 95
11.5.5 Section-wise Research Methodology 96
11.6 Contact Us 97
11.7 Disclaimer 97



List of Tables

Table 1: Contract Research Organization Market to 2018, Comparison of CAGR of RandD Expenditure vs. CAGR Turnover for the Top 10 Pharmaceutical Companies, 2004-2011 15
Table 2: Contract Research Organization Market to 2018, Global, Revenue ($bn), 2008-2018 44
Table 3: Contract Research Organization Market to 2018, Global, RandD Outsourcing Market (%), 2008-2018 45
Table 4: Contract Research Organization Market to 2018, Global, Revenue by Geography ($bn), 2011-2018 46
Table 5: Contract Research Organization Market to 2018, Global, Trend Analysis by Geography (%), 2011-2018 47
Table 6: Contract Research Organization Market to 2018, Global, Revenue by Phase ($bn), 2011-2018 48
Table 7: Contract Research Organization Market to 2018, Global, Trend Analysis by Phase,(%), 2011-2018 49
Table 8: Contract Research Organization Market to 2018, Clinical Trial Market, Argentina ($m), 2008-2018 50
Table 9: Contract Research Organization Market to 2018, Clinical Trial Market, India, ($m), 2008-2018 59
Table 10: Contract Research Organization Market to 2018, Clinical Trial Market, China, ($m), 2008-2018 70
Table 11: Contract Research Organization Market to 2018, Market Share Analysis of Contract Research Organizations (%), 2011 77
Table 12: Contract Research Organization Market to 2018, Quintiles, Strategic Consolidations, 2010-2012 79
Table 13: Contract Research Organization Market to 2018, Covance, Strategic Consolidations, 2010-2012 82
Table 14: Contract Research Organization Market to 2018, Icon, Strategic Consolidations, 2010-2011 84
Table 15: Contract Research Organization Market to 2018, PPD, Strategic Consolidations, 2010-2012 86
Table 16: Contract Research Organization Market to 2018, Charles River Laboratories, Strategic Consolidations, 2010-2012 89
Table 17: Contract Research Organization Market to 2018, Parexel, Strategic Consolidations, 2010-2012 91



List of Figures

Figure 1: Contract Research Organization Market to 2018, Comparison of CAGR of RandD Expenditure vs. CAGR Turnover for the Top 10 Pharmaceutical Companies, 2004-2011 15
Figure 2: Contract Research Organization Market to 2018, Key Factors Responsible for Study Timeline Reduction by Site Management Organizations, 2011 17
Figure 3: Contract Research Organization Market to 2018, Site Initiation Process, 2011 17
Figure 4: Contract Research Organization Market to 2018, Clinical Data Management System Flow, Global, 2011 22
Figure 5: Contract Research Organization Market to 2018, TCS - Eli Lilly Outsourcing Deal, Client Rationale, November 2006 24
Figure 6: Contract Research Organization Market to 2018, Cognizant - AstraZeneca Outsourcing Deal, Client-Vendor Rationale, March 2008 24
Figure 7: Contract Research Organization Market to 2018, Typical Clinical Trial Management System, 2011 26
Figure 8: Contract Research Organization Market to 2018, Key Measures for Effective RandD Restructuring, 2011 28
Figure 9: Contract Research Organization Market to 2018, GlaxoSmithKline RandD Restructuring, CEO Statement, February 2009 29
Figure 10: Contract Research Organization Market to 2018, Pfizer RandD Restructuring, President - BioTherapeutics RandD Statement, November 2009 30
Figure 11: Contract Research Organization Market to 2018, AstraZeneca RandD Restructuring, CEO and EVP Statement 31
Figure 12: Contract Research Organization Market to 2018, Sanofi RandD Restructuring, CEO Statement, June 2009 32
Figure 13: Contract Research Organization Market to 2018, Governance in Innovative Medicines Initiative, 2011 34
Figure 14: Contract Research Organization Market to 2018, Process of Approval for RandD Projects in Innovative Medicines Initiative, 2011 35
Figure 15: Contract Research Organization Market to 2018, Collaboration between Firocuz and GlaxoSmithKline, Timeline, 1985-2009 41
Figure 16: Contract Research Organization Market to 2018, Global, Revenue ($bn), 2008-2018 44
Figure 17: Contract Research Organization Market to 2018, Global, RandD Outsourcing Market (%), 2008-2018 45
Figure 18: Contract Research Organization Market to 2018, Global, Revenue by Geography ($bn), 2011-2018 46
Figure 19: Contract Research Organization Market to 2018, Global, Trend Analysis by Geography (%), 2011-2018 47
Figure 20: Contract Research Organization Market to 2018, Global, Revenue by Phase ($bn), 2011-2018 48
Figure 21: Contract Research Organization Market to 2018, Global, Trend Analysis by Phase, (%), 2011-2018 49
Figure 22: Contract Research Organization Market to 2018, Clinical Trial Market, Argentina ($m), 2008-2018 50
Figure 23: Contract Research Organization Market to 2018, Abel Santos and Asociados, Company Profile, 2011 51
Figure 24: Contract Research Organization Market to 2018, Activa CRO, Company Profile, 2011 52
Figure 25: Contract Research Organization Market to 2018, Blanchard and Asociados, Company Profile, 2011 53
Figure 26: Contract Research Organization Market to 2018, EGCP, Company Profile, 2011 54
Figure 27: Contract Research Organization Market to 2018, Klixar, Company Profile, 2011 55
Figure 28: Contract Research Organization Market to 2018, LatinClin, Company Profile, 2011 56
Figure 29: Contract Research Organization Market to 2018, Mmatiss, Company Profile, 2011 57
Figure 30: Contract Research Organization Market to 2018, Estudios Clínicos Latinoamerica, Company Profile, 2011 58
Figure 31: Contract Research Organization Market to 2018, Clinical Trial Market, India, ($m), 2008-2018 59
Figure 32: Contract Research Organization Market to 2018, Reliance Life Sciences, India, 2011 60
Figure 33: Contract Research Organization Market to 2018, Asian Clinical Trials, India, 2011 61
Figure 34: Contract Research Organization Market to 2018, DiagnoSearch Life Sciences, India, 2011 62
Figure 35: Contract Research Organization Market to 2018, ClinInvent, India, 2011 63
Figure 36: Contract Research Organization Market to 2018, Synchron Research Services, India, 2011 64
Figure 37: Contract Research Organization Market to 2018, Lambda Therapeutics, India, 2011 65
Figure 38: Contract Research Organization Market to 2018, GVK Biosciences, India, 2011 66
Figure 39: Contract Research Organization Market to 2018, Veeda Clinical Research, India, 2011 67
Figure 40: Contract Research Organization Market to 2018, Ecron Acunova, India, 2011 68
Figure 41: Contract Research Organization Market to 2018, Siro Clinpharm, India, 2011 69
Figure 42: Contract Research Organization Market to 2018, Clinical Trial Market, China, ($m), 2008-2018 70
Figure 43: Contract Research Organization Market to 2018, Boji Medicine Services Co. Ltd, Company Profile, 2011 71
Figure 44: Contract Research Organization Market to 2018, Giant Med-Pharma Services Inc, Company Profile, 2011 72
Figure 45: Contract Research Organization Market to 2018, InCrom, Company Profile, 2011 73
Figure 46: Contract Research Organization Market to 2018, Pharmaron, Company Profile, 2011 74
Figure 47: Contract Research Organization Market to 2018, Venturepharm Service Group, Company Profile, 2011 75
Figure 48: Contract Research Organization Market to 2018, Market Share Analysis of Contract Research Organizations (%), 2011 76
Figure 49: Contract Research Organization Market to 2018, Quintiles, Snapshot, 2011 78
Figure 50: Contract Research Organization Market to 2018, Covance, Snapshot, 2011 81
Figure 51: Top 20 Contract Research Organizations, ICON, Snapshot, 2011 83
Figure 52: Contract Research Organization Market to 2018, Pharmaceutical Product Development, Snapshot, 2011 85
Figure 53: Contract Research Organization Market to 2018, Charles River Laboratories, Snapshot, 2011 88
Figure 54: Contract Research Organization Market to 2018, Parexel, Snapshot, 2011 90



Companies Mentioned

Quintiles Transnational Corp
Covance Inc
Pharmaceutical Product Development Inc
Charles River Laboratories International, Inc
Parexel International

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Clare

+1 339 368 6001

Purchase Reports From Reputable Market Research Publishers

Proteomics Markets for Research and IVD Applications

Proteomics Markets for Research and IVD Applications

  • $ 4 200
  • Industry report
  • September 2014
  • by Kalorama Information

This Kalorama Information report defines markets and identifies trends for proteomics applications, both in their research use and in IVD. Proteomics is the study of proteins, including the study of the ...

Biologicals in Oncology Drug Pipeline Update 2014

Biologicals in Oncology Drug Pipeline Update 2014

  • $ 3 749
  • Industry report
  • July 2014
  • by Bioseeker

This drug pipeline update covers a wide array of biological drugs, such as: antibodies,proteins, peptides, DNA, RNA and cellular therapies. There are today 908 companies plus partners developing 1686 biological ...

Biologicals in Oncology: Drug Pathway Analyzer 2014

Biologicals in Oncology: Drug Pathway Analyzer 2014

  • $ 3 675
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 1421 biological drugs known to affect more than 266 specific intracellular signaling pathways for the treatment ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.